5-MeO-DMT   Click here for help

GtoPdb Ligand ID: 145

Synonyms: 5-methoxydimethyltryptamine | MeODMT
PDB Ligand
Compound class: Synthetic organic
Comment: 5-MeO-DMT is a tryptamine class psychedelic substance that stimulates the serotonin system and regulates mood.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 28.26
Molecular weight 218.14
XLogP 1.95
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1ccc2c(c1)c(CCN(C)C)c[nH]2
Isomeric SMILES COc1ccc2c(c1)c(CCN(C)C)c[nH]2
InChI InChI=1S/C13H18N2O/c1-15(2)7-6-10-9-14-13-5-4-11(16-3)8-12(10)13/h4-5,8-9,14H,6-7H2,1-3H3
InChI Key ZSTKHSQDNIGFLM-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
A fast-acting intranasal powder formulation of 5-MeO-DMT (the benzoate salt named BPL-003) is a clinical candidate for the treatment of treatment-resistant depression, including depression associated with alcohol use disorder.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05870540 BPL-003 Efficacy and Safety in Treatment Resistant Depression Phase 2 Interventional Beckley Psytech Limited
NCT05660642 An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression Phase 2 Interventional Beckley Psytech Limited 5
NCT05674929 An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder Phase 2 Interventional Beckley Psytech Limited 5